Vical Incorporated was a U.S. biotechnology company focused on developing DNA-based vaccines and immunotherapies, as well as related delivery technologies. Its programs targeted infectious diseases and cancer through clinical-stage biopharmaceutical research and development.
No data available
Are you interested in the impact of this company or this ETF?
It seems we haven't collected any data here yet. Just let us know and we will try to find data as soon as possible. Thank you for your feedback!